Biomarin Pharmaceutical Inc
NASDAQ: BMRN
$82.44
-$1.36 (-1.6%)
Closing price May 3, 2024
BMRN Articles
Wednesday's top analyst upgrades and downgrades included Academy Sports & Outdoors, Arista Networks, Colgate-Palmolive, Expedia, Global Payments, Huntsman, InMode, ON Semiconductor and Zoominfo...
Published:
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal,...
Published:
Friday's top analyst upgrades and downgrades included Amgen, Amphenol, Harley-Davidson, Hertz Global, Las Vegas Sands, Masco, Meta Platforms, NXP Semiconductors, Oshkosh, PayPal, Pinterest,...
Published:
Monday’s additional top analyst upgrades and downgrades included Agilent Technologies, Barrick Gold, Deere, Kellogg, Marathon Oil, Newmont, Penn National Gaming, Spotify Technology and Verizon...
Published:
Growth investors who are more aggressive and looking for Wall Street’s best ideas amid the current market uncertainties may want to consider these five Goldman Sachs Conviction List picks. If their...
Published:
Monday afternoon's analyst upgrades and downgrades included Activision Blizzard, BioMarin, eBay and Teladoc.
Published:
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Published:
Thursday’s top analyst upgrades and downgrades included Baker Hughes, BioMarin Pharmaceutical, Cisco Systems, Haliburton, Macy’s, Schlumberger and Sherwin-Williams.
Published:
Friday's top analyst upgrades and downgrades included ADS, BioMarin Pharmaceutical, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties and U.S. Steel.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
Published:
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Published:
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
Published:
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack,...
Published: